Tag: Center for Rapid Surveillance of Tobacco

  • Rutgers’ CRST Touts Ability to Predict Industry Trends

    Rutgers’ CRST Touts Ability to Predict Industry Trends

    Researchers at Rutgers University’s Center for Rapid Surveillance of Tobacco (CRST) say their real-time monitoring system, developed after Juul’s rapid rise, is helping regulators identify emerging nicotine products before they become widespread. In a special issue of Preventive Medicine Reports, the center detailed how it combines retail audits, sales data, marketing surveillance, and consumer surveys to track more than 50 tobacco and nicotine brands.

    “Large federal surveys are like an aircraft carrier in the ocean,” said Cristine Delnevo, CRST’s director and principal investigator. “They’re extremely powerful in many ways, but they can’t pivot quickly.”

    The researchers highlighted the system’s early identification of unauthorized disposable vape brand Geek Bar, which they correctly predicted would surpass Juul in sales by late 2025, as well as the rapid growth of nicotine pouches led by Zyn. The center also found that pouch users are predominantly adults with prior cigarette or other tobacco use, while emphasizing that continued surveillance is needed to monitor whether marketing begins attracting new youth users as the category expands.

    The center, which is in the fourth year of its five-year contract with the FDA and the National Cancer Institute, publishes regularly updated fact sheets on emerging brands on its website.

  • Funding for Tobacco Surveillance Center

    Funding for Tobacco Surveillance Center

    Credit: JHVEPhoto

    The U.S. Food and Drug Administration and the National Institutes of Health (NIH) have awarded funding for a new Center for Rapid Surveillance of Tobacco (CRST). Through rapid surveillance and reporting of information, CRST will enhance the Center for Tobacco Products (CTP) and the research community’s ability to understand, document and quantify changes in the tobacco product marketplace and tobacco use patterns.

    Research results from the CRST are expected to generate findings and data that are directly relevant in informing the FDA’s regulation of the manufacture, distribution and marketing of tobacco products to protect public health. In particular, the CRST will support more time-sensitive data collection, analysis and reporting—making potentially actionable information available before more traditional data collection methods. 

    “Given the rapidly evolving tobacco landscape, it’s critical that we have nimble surveillance tools that can keep pace to best protect public health,” said Brian King, director of the FDA’s CTP. “This new center is another important addition to our surveillance toolbox to help identify emerging issues and to inform timely action.”

    The CRST is supported through the Tobacco Regulatory Science Program, an interagency partnership between the NIH and CTP to foster tobacco regulatory research. After undergoing a competitive funding announcement, the CRST is being administered through a cooperative agreement under award number U01CA278695. The work is led by Rutgers Center of Excellence in Rapid Surveillance of Tobacco with substantial involvement from a large collaborative network that triangulates multiple data sources, federal scientific staff at CDC, NIH and CTP as well as external advisors with relevant expertise.